Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Breitruck

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|July 10, 2020
Daniel Vogele, Jochen Breitruck, Stefan Andreas Schmidt
Blood|October 24, 2002
Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group UlmStefan Fröhling, Richard F Schlenk, Jochen Breitruck, et al.
Emerging Infectious Diseases|September 29, 2025
Fatal Pneumocephalus Caused by Hypervirulent Klebsiella pneumoniae, GermanyNico Gläser, Nina Schwab, Yvonne Pfeifer, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|July 10, 2020
Daniel Vogele, Jochen Breitruck, Stefan Andreas Schmidt
Blood|October 24, 2002
Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group UlmStefan Fröhling, Richard F Schlenk, Jochen Breitruck, et al.
Emerging Infectious Diseases|September 29, 2025
Fatal Pneumocephalus Caused by Hypervirulent Klebsiella pneumoniae, GermanyNico Gläser, Nina Schwab, Yvonne Pfeifer, et al.
Pageof 1